204 related articles for article (PubMed ID: 29355732)
1. The quest for endothelial atypical cannabinoid receptor: BK
Bondarenko AI; Panasiuk O; Drachuk K; Montecucco F; Brandt KJ; Mach F
Vascul Pharmacol; 2018 Mar; 102():44-55. PubMed ID: 29355732
[TBL] [Abstract][Full Text] [Related]
2. N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor.
McHugh D; Hu SS; Rimmerman N; Juknat A; Vogel Z; Walker JM; Bradshaw HB
BMC Neurosci; 2010 Mar; 11():44. PubMed ID: 20346144
[TBL] [Abstract][Full Text] [Related]
3. A GPR18-based signalling system regulates IOP in murine eye.
Caldwell MD; Hu SS; Viswanathan S; Bradshaw H; Kelly ME; Straiker A
Br J Pharmacol; 2013 Jun; 169(4):834-43. PubMed ID: 23461720
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid and lipid-mediated vasorelaxation in retinal microvasculature.
MacIntyre J; Dong A; Straiker A; Zhu J; Howlett SE; Bagher A; Denovan-Wright E; Yu DY; Kelly ME
Eur J Pharmacol; 2014 Jul; 735():105-14. PubMed ID: 24751709
[TBL] [Abstract][Full Text] [Related]
5. N-Arachidonoyl glycine suppresses Na⁺/Ca²⁺ exchanger-mediated Ca²⁺ entry into endothelial cells and activates BK(Ca) channels independently of GPCRs.
Bondarenko AI; Drachuk K; Panasiuk O; Sagach V; Deak AT; Malli R; Graier WF
Br J Pharmacol; 2013 Jun; 169(4):933-48. PubMed ID: 23517055
[TBL] [Abstract][Full Text] [Related]
6. G protein-coupled endothelial receptor for atypical cannabinoid ligands modulates a Ca2+-dependent K+ current.
Begg M; Mo FM; Offertaler L; Bátkai S; Pacher P; Razdan RK; Lovinger DM; Kunos G
J Biol Chem; 2003 Nov; 278(46):46188-94. PubMed ID: 12952947
[TBL] [Abstract][Full Text] [Related]
7. Direct activation of Ca
Bondarenko AI; Panasiuk O; Okhai I; Montecucco F; Brandt KJ; Mach F
Eur J Pharmacol; 2017 Jun; 805():14-24. PubMed ID: 28327344
[TBL] [Abstract][Full Text] [Related]
8. Ca
Bondarenko AI; Panasiuk O; Okhai I; Montecucco F; Brandt KJ; Mach F
J Mol Cell Cardiol; 2018 Feb; 115():54-63. PubMed ID: 29305938
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.
Járai Z; Wagner JA; Varga K; Lake KD; Compton DR; Martin BR; Zimmer AM; Bonner TI; Buckley NE; Mezey E; Razdan RK; Zimmer A; Kunos G
Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14136-41. PubMed ID: 10570211
[TBL] [Abstract][Full Text] [Related]
10. GPR55 agonist lysophosphatidylinositol and lysophosphatidylcholine inhibit endothelial cell hyperpolarization via GPR-independent suppression of Na
Bondarenko AI; Montecucco F; Panasiuk O; Sagach V; Sidoryak N; Brandt KJ; Mach F
Vascul Pharmacol; 2017 Feb; 89():39-48. PubMed ID: 28064014
[TBL] [Abstract][Full Text] [Related]
11. Endothelial atypical cannabinoid receptor: do we have enough evidence?
Bondarenko AI
Br J Pharmacol; 2014 Dec; 171(24):5573-88. PubMed ID: 25073723
[TBL] [Abstract][Full Text] [Related]
12. The endogenous lipid N-arachidonoyl glycine is hypotensive and nitric oxide-cGMP-dependent vasorelaxant.
Al Suleimani YM; Al Mahruqi AS
Eur J Pharmacol; 2017 Jan; 794():209-215. PubMed ID: 27890711
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid receptor type 1 activation by arachidonylcyclopropylamide in rat aortic rings causes vasorelaxation involving calcium-activated potassium channel subunit alpha-1 and calcium channel, voltage-dependent, L type, alpha 1C subunit.
Sánchez-Pastor E; Andrade F; Sánchez-Pastor JM; Elizalde A; Huerta M; Virgen-Ortiz A; Trujillo X; Rodríguez-Hernández A
Eur J Pharmacol; 2014 Apr; 729():100-6. PubMed ID: 24561046
[TBL] [Abstract][Full Text] [Related]
14. Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery.
Ho WS; Hiley CR
Br J Pharmacol; 2003 Apr; 138(7):1320-32. PubMed ID: 12711633
[TBL] [Abstract][Full Text] [Related]
15. Role of Endothelium in Abnormal Cannabidiol-Induced Vasoactivity in Retinal Arterioles.
Su EN; Kelly ME; Cringle SJ; Yu DY
Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):4029-37. PubMed ID: 26098470
[TBL] [Abstract][Full Text] [Related]
16. Activation of GPR18 by cannabinoid compounds: a tale of biased agonism.
Console-Bram L; Brailoiu E; Brailoiu GC; Sharir H; Abood ME
Br J Pharmacol; 2014 Aug; 171(16):3908-17. PubMed ID: 24762058
[TBL] [Abstract][Full Text] [Related]
17. The novel endocannabinoid receptor GPR18 is expressed in the rostral ventrolateral medulla and exerts tonic restraining influence on blood pressure.
Penumarti A; Abdel-Rahman AA
J Pharmacol Exp Ther; 2014 Apr; 349(1):29-38. PubMed ID: 24431468
[TBL] [Abstract][Full Text] [Related]
18. N-arachidonoyl glycine, an endogenous lipid that acts as a vasorelaxant via nitric oxide and large conductance calcium-activated potassium channels.
Parmar N; Ho WS
Br J Pharmacol; 2010 Jun; 160(3):594-603. PubMed ID: 20136843
[TBL] [Abstract][Full Text] [Related]
19. Atypical cannabinoid stimulates endothelial cell migration via a Gi/Go-coupled receptor distinct from CB1, CB2 or EDG-1.
Mo FM; Offertáler L; Kunos G
Eur J Pharmacol; 2004 Apr; 489(1-2):21-7. PubMed ID: 15063151
[TBL] [Abstract][Full Text] [Related]
20. ACPA and JWH-133 modulate the vascular tone of superior mesenteric arteries through cannabinoid receptors, BK
López-Dyck E; Andrade-Urzúa F; Elizalde A; Ferrer-Villada T; Dagnino-Acosta A; Huerta M; Osuna-Calleros Z; Rangel-Sandoval C; Sánchez-Pastor E
Pharmacol Rep; 2017 Dec; 69(6):1131-1139. PubMed ID: 29128791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
